Bio Protocol vs Metis — how do they compare? Bio Protocol trades at Rp427.93 (market cap Rp974,32M, Rp148,57M 24h volume), while Metis trades at Rp41,680 (market cap Rp321,87M, Rp20,89M 24h volume). The key difference: Bio Protocol is far larger — about 3× Metis's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 7,7M / 10M METIS (78%) for Metis. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Metis for 77 Days on average.
| BIO | METIS | |
|---|---|---|
Market Cap | Rp974,32M | Rp321,87M |
Volume (24h) | Rp148,57M | Rp20,89M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 7,7M / 10M METIS (78%) |
Typical Hold Time | 18 Days | 77 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Metis is currently trading at Rp42,985 with a bearish technical signal, showing weak momentum below key resistance levels. The token faces selling pressure with moving averages indicating a downtrend, though oscillators remain neutral. With 78% of the 10 million max supply in circulation and an average hold time of 77 days, the asset shows moderate distribution stability. Recent ecosystem developments include ongoing protocol upgrades to enhance Layer 2 scalability and reduce transaction costs.
Overall outlook remains cautious with technical weakness dominating. Key opportunities lie in potential Layer 2 adoption growth, while major risks include continued bearish momentum and crypto market volatility. Investors should monitor support at Rp41,711 for potential breakdown scenarios.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Metis is an Ethereum Layer-2 scaling solution aiming to solve the blockchain trilemma: that blockchains cannot be decentralized, secure, and scalable simultaneously. It also strives to solve Ethereum's biggest challenges: speed, cost and scalability.
Read more on METIS →